 ELMWOOD PARK, N.J., Aug. 16, 2021 PRNewswire -- BioReference Laboratories, Inc., an OPKO Health company NASDAQ:OPK, today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. 